مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

349
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

158
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

SEROLOGIC RESPONSE TO HEPATITIS B VACCINE IN HEALTH CARE WORKERS, KERMANSHAH, IRAN

Pages

  147-149

Abstract

 Background: HEPATITIS B is a major infectious risk factor for HEALTH-CARE WORKERS (HCWs) and public- safety workers. Although seroconversion rate following HEPATITIS B vaccination is estimated to be more than 90%, SEROLOGIC RESPONSE to HEBERBIOVAC HB VACCINE currently given in our center in Kermanshah province has been varied in different experiences, So, this study was conducted to determine SEROLOGIC RESPONSE in HCWs. Methods: In a descriptive-cross sectional study, in 138 HbcAb from 10 health care centers, HbcAb negatives and vaccinated with HEBERBIOVAC HB (Cuba made, available VACCINE in Iran), HbsAb titer was assessed by ELISA. SEROLOGIC RESPONSE as antibody titer equal or more than 10mIU/ml considered protective level (serologic responder). The data were analyzed by SPSS software, using X² and Fisher exact test. Results: Within 138 HCWs(60.1% female and 39.9% male), 69.6% had SEROLOGIC RESPONSE. The age had significant role in SEROLOGIC RESPONSE rate, but sex, weight, smoking and interval from the last time of VACCINE reception were not effective factors. Conclusion: SEROLOGIC RESPONSE rate to HBV VACCINE in Kermanshah was much lower than other experiences. We need more information about the efficacy of HEBERBIOVAC HB in high-risk groups and general population, the reasons of low efficacy and increasing SEROLOGIC RESPONSE.      

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    JANBAKHSH, A.R., SAYAD, B., VAZIRI, S., & AIENI, P.. (2005). SEROLOGIC RESPONSE TO HEPATITIS B VACCINE IN HEALTH CARE WORKERS, KERMANSHAH, IRAN. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), 10(3), 147-149. SID. https://sid.ir/paper/528147/en

    Vancouver: Copy

    JANBAKHSH A.R., SAYAD B., VAZIRI S., AIENI P.. SEROLOGIC RESPONSE TO HEPATITIS B VACCINE IN HEALTH CARE WORKERS, KERMANSHAH, IRAN. JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS)[Internet]. 2005;10(3):147-149. Available from: https://sid.ir/paper/528147/en

    IEEE: Copy

    A.R. JANBAKHSH, B. SAYAD, S. VAZIRI, and P. AIENI, “SEROLOGIC RESPONSE TO HEPATITIS B VACCINE IN HEALTH CARE WORKERS, KERMANSHAH, IRAN,” JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS), vol. 10, no. 3, pp. 147–149, 2005, [Online]. Available: https://sid.ir/paper/528147/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button